Bioceres Crop Solutions Corp. BIOX
Annual
Quarterly
FY2025 · ended Jun 30, 2025 · Revenue $333.34M, -28.3% YoY · Filed Nov 10, 2025
Bioceres Crop Solutions Corp. (BIOX) files with the SEC under industry code 2870, Agricultural Chemicals. In fiscal 2025, which ended Jun 30, 2025, it reported revenue of $333.3 million and a net loss of $58.8 million. Free cash flow was $44.3 million. As of Jun 30, 2025 it held $32.7 million in cash and investments and $174.3 million in total debt.
Revenue
$333.34M
-28.3% vs prior year
Net income
$-58.85M
-907.3% vs prior year
Operating cash flow
$49.91M
+19.6% vs prior year
Free cash flow
$44.26M
+38.6% vs prior year
EPS
$-0.88
-1402.2% vs prior year
Dividend per share
None
Shares outstanding
63.82M
+0.9% vs prior year
Net cash
$-141.64M
FY 2025
Operating margin
-0.7%
FY 2025
Company profile
- Industry
- Agricultural Chemicals (SIC 2870)
- Listed as
- BIOX (Nasdaq)
- Fiscal year ends
- June 30
- Incorporated in
- Cayman Islands
- Headquarters
- George Town, Grand Cayman, Cayman Islands
- SEC filer status
- Accelerated filer
- SEC CIK
- 1769484
Other Agricultural Chemicals companies
- Nutrien Ltd. NTR
- CF Industries Holdings, Inc. CF
- Mosaic Co MOS
- Scotts Miracle-Gro Co SMG
- Cibus, Inc. CBUS
- American Vanguard Corp AVD
- Bion Environmental Technologies Inc BNET
- Fort Technology Inc FRTT
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2025 Jun 30, 2025 |
FY 2024 Jun 30, 2024 |
FY 2023 Jun 30, 2023 |
FY 2022 Jun 30, 2022 |
FY 2021 Jun 30, 2021 |
|---|---|---|---|---|---|
| Revenue | $333.3M | $464.8M | $419.4M | $328.5M | $206.7M |
| Operating income | -$2.2M | $45.9M | $54.2M | $39.9M | $38.4M |
| Net income | -$58.8M | $7.3M | $20.2M | -$3.9M | -$3.8M |
| Diluted EPS | -$0.88 | $0.07 | $0.30 | -$0.17 | -$0.18 |
| Operating cash flow | $49.9M | $41.7M | $2.6M | -$17.5M | -$6.2M |
| Free cash flow | $44.3M | $31.9M | -$8.8M | -$21.0M | -$9.0M |
| Total assets | $763.6M | $852.5M | $818.1M | $518.2M | $394.6M |
| Total liabilities | $468.4M | $501.2M | $487.6M | $359.9M | $304.3M |
| Stockholders' equity | $295.2M | $351.4M | $330.5M | $158.3M | $90.3M |
| Cash and investments | $32.7M | $44.5M | $48.1M | $33.5M | $36.0M |
| Total debt | $174.3M | $190.1M | $182.2M | $157.2M | $125.9M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 20-F | Annual report (foreign issuer) | Oct 30, 2026 | Jun 30, 2026 |
| 6-K | Current report (foreign issuer) | Sep 21, 2026 | Sep 18, 2026 |
| 6-K | Current report (foreign issuer) | Sep 16, 2026 | Sep 15, 2026 |
| 6-K | Current report (foreign issuer) | Jun 22, 2026 | Jun 19, 2026 |
| 6-K | Current report (foreign issuer) | Jun 1, 2026 | Jun 1, 2026 |
| 6-K | Current report (foreign issuer) | May 12, 2026 | May 12, 2026 |
All 280 Bioceres Crop Solutions Corp. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.